Mougari, S., Favède, V., Predella, C., Reynard, O., Durand, S., Mazelier, M., Pizzioli, E., Decimo, D., Bovier, F. T., Lapsley, L. M., Castagna, C., Lieberman, N. A. P., Noel, G., Mathieu, C., Malissen, B., Briese, T., Greninger, A. L., Alabi, C. A., Dorrello, N. V., … Horvat, B. (2025). Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity. Communications Biology, 8(1). https://doi.org/10.1038/s42003-025-07491-4
Columbia Affiliation:
Subjects:
SARS-CoV-2
(MeSH)
COVID-19
(MeSH)
Lipopeptides
(MeSH)
Administration, Intranasal
(MeSH)
Mice, Transgenic
(MeSH)
Coronavirus Disease 2019 Research
(OpenAlex Topic)
Coronavirus Disease 2019
(OpenAlex Topic)
Innate Immunity to Viral Infection
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1038/s42003-025-07491-4
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex